MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simpson, M. M.
Right arrow Articles by Javitch, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simpson, M. M.
Right arrow Articles by Javitch, J. A.

Vol. 56, Issue 6, 1116-1126, December 1999

Dopamine D4/D2 Receptor Selectivity Is Determined by A Divergent Aromatic Microdomain Contained within the Second, Third, and Seventh Membrane-Spanning Segments

Merrill M. Simpson, Juan A. Ballesteros, Victor Chiappa, Jiayun Chen, Makiko Suehiro, Deborah S. Hartman,1 Thierry Godel, Lenore A. Snyder,2 Thomas P. Sakmar, and Jonathan A. Javitch

Center for Molecular Recognition (M.M.S., J.A.B., V.C., M.S., J.A.J.) and Departments of Psychiatry and Pharmacology (J.A.J.), Columbia University College of Physicians and Surgeons, New York, New York; Department of Physiology and Biophysics, Mount Sinai School of Medicine, New York, New York (J.A.B.); F. Hoffmann-La Roche Ltd., Pharma Preclinical Research, Basel, Switzerland (D.S.H., T.G.); and Howard Hughes Medical Institute (T.P.S.) and Laboratory of Molecular Biology and Biochemistry (L.S., T.P.S.), Rockefeller University, New York, New York

Conserved features of the sequences of dopamine receptors and of homologous G-protein-coupled receptors point to regions, and amino acid residues within these regions, that contribute to their ligand binding sites. Differences in binding specificities among the catecholamine receptors, however, must stem from their nonconserved residues. Using the substituted-cysteine accessibility method, we have identified the residues that form the surface of the water-accessible binding-site crevice in the dopamine D2 receptor. Of approximately 80 membrane-spanning residues that differ between the D2 and D4 receptors, only 20 were found to be accessible, and 6 of these 20 are conservative aliphatic substitutions. In a D2 receptor background, we mutated the 14 accessible, nonconserved residues, individually or in combinations, to the aligned residues in the D4 receptor. We also made the reciprocal mutations in a D4 receptor background. The combined substitution of four to six of these residues was sufficient to switch the affinity of the receptors for several chemically distinct D4-selective antagonists by three orders of magnitude in both directions (D2- to D4-like and D4- to D2-like). The mutated residues are in the second, third, and seventh membrane-spanning segments (M2, M3, M7) and form a cluster in the binding-site crevice. Mutation of a single residue in this cluster in M2 was sufficient to increase the affinity for clozapine to D4-like levels. We can rationalize the data in terms of a set of chemical moieties in the ligands interacting with a divergent aromatic microdomain in M2-M3-M7 of the D2 and D4 receptors.

Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Nutr.Home page
W. A. Goddard III and R. Abrol
3-Dimensional Structures of G Protein-Coupled Receptors and Binding Sites of Agonists and Antagonists
J. Nutr., June 1, 2007; 137(6): 1528S - 1538S.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. A. Al-Fulaij, Y. Ren, M. Beinborn, and A. S. Kopin
Identification of Amino Acid Determinants of Dopamine 2 Receptor Synthetic Agonist Function
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 298 - 307.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
H. Lan, C. J. DuRand, M. M. Teeter, and K. A. Neve
Structural Determinants of Pharmacological Specificity Between D1 and D2 Dopamine Receptors
Mol. Pharmacol., January 1, 2006; 69(1): 185 - 194.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. Kortagere, P. Gmeiner, H. Weinstein, and J. A. Schetz
Certain 1,4-Disubstituted Aromatic Piperidines and Piperazines with Extreme Selectivity for the Dopamine D4 Receptor Interact with a Common Receptor Microdomain
Mol. Pharmacol., December 1, 2004; 66(6): 1491 - 1499.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Y. S. Kalani, N. Vaidehi, S. E. Hall, R. J. Trabanino, P. L. Freddolino, M. A. Kalani, W. B. Floriano, V. W. T. Kam, and W. A. Goddard III
The predicted 3D structure of the human D2 dopamine receptor and the binding site and binding affinities for agonists and antagonists
PNAS, March 16, 2004; 101(11): 3815 - 3820.
[Abstract] [Full Text] [PDF]

Home page
 Biophys. JHome page
K. A. Selz, A. J. Mandell, M. F. Shlesinger, V. Arcuragi, and M. J. Owens
Designing Human m1 Muscarinic Receptor-Targeted Hydrophobic Eigenmode Matched Peptides as Functional Modulators
Biophys. J., March 1, 2004; 86(3): 1308 - 1331.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Govaerts, A. Bondue, J.-Y. Springael, M. Olivella, X. Deupi, E. Le Poul, S. J. Wodak, M. Parmentier, L. Pardo, and C. Blanpain
Activation of CCR5 by Chemokines Involves an Aromatic Cluster between Transmembrane Helices 2 and 3
J. Biol. Chem., January 10, 2003; 278(3): 1892 - 1903.
[Abstract] [Full Text] [PDF]

Home page
 Biophys. JHome page
M. G. Paterlini
Structure Modeling of the Chemokine Receptor CCR5: Implications for Ligand Binding and Selectivity
Biophys. J., December 1, 2002; 83(6): 3012 - 3031.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
N. Ben-Jonathan and R. Hnasko
Dopamine as a Prolactin (PRL) Inhibitor
Endocr. Rev., December 1, 2001; 22(6): 724 - 763.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
J. A. Ballesteros, L. Shi, and J. A. Javitch
Structural Mimicry in G Protein-Coupled Receptors: Implications of the High-Resolution Structure of Rhodopsin for Structure-Function Analysis of Rhodopsin-Like Receptors
Mol. Pharmacol., July 1, 2001; 60(1): 1 - 19.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics